MCOLN1 rs77574888: Understanding Mucolipidosis Type IV Carrier Status
The rs77574888 variant is a specific genetic change in the MCOLN1 gene known as a splice-acceptor mutation. It is primarily studied as a carrier marker for Mucolipidosis type IV, an autosomal recessive lysosomal storage disorder.
What each genotype means
Typical MCOLN1 function
This genotype represents the common, functional sequence for this region of the MCOLN1 gene. Individuals with this result are not expected to be carriers of the specific splice-acceptor mutation associated with Mucolipidosis type IV.
This is the most common genotype across all global populations.
Carrier of MCOLN1 variant
This genotype indicates you carry one copy of the c.406-2A>G splice-acceptor mutation, also known as IVS3-2A>G. Carriers are typically asymptomatic and do not have Mucolipidosis type IV, but they may pass this variant to their children. If your reproductive partner is also a carrier, there is a 25% chance for each pregnancy to be affected by this condition.
This genotype is found in approximately 1 in 100 to 1 in 127 individuals of Ashkenazi Jewish ancestry.
Potential Mucolipidosis type IV
This genotype indicates the presence of two copies of the c.406-2A>G mutation. This variant is associated with Mucolipidosis type IV, a condition that typically presents with developmental delay and vision loss in early childhood. Please consult with a medical geneticist or healthcare provider to discuss these results and any necessary clinical follow-up.
This genotype is extremely rare in the general population.
What is the rs77574888 Variant?
The rs77574888 variant, often referred to in clinical literature as c.406-2A>G or IVS3-2A>G, is a specific alteration located within the MCOLN1 gene. This gene is situated on chromosome 19. In genetic terms, this variant is classified as a splice-acceptor site mutation. Splice sites are critical sequences in DNA that act as signals for the cell to correctly process messenger RNA (mRNA) before it is translated into a functional protein. When a mutation occurs at a splice-acceptor site, it can disrupt the normal splicing process, often leading to the production of an incomplete or non-functional protein. Because this variant is located in a region essential for proper gene expression, it is a primary focus in clinical genetic screening, particularly for individuals with specific ancestral backgrounds where this mutation is more frequently observed.
The Role of the MCOLN1 Gene
The MCOLN1 gene provides the instructions for the body to produce a protein called mucolipin-1. This protein is primarily found in the membranes of lysosomes and endosomes, which are specialized compartments within cells responsible for breaking down and recycling waste materials. Mucolipin-1 functions as a non-selective cation channel, meaning it helps regulate the flow of ions like calcium into and out of these cellular compartments. This ion transport is essential for the proper trafficking of lipids and proteins. When mucolipin-1 is absent or non-functional, these substances cannot be transported or recycled efficiently, leading to their accumulation within the cell. This buildup is the hallmark of lysosomal storage disorders, which can interfere with the normal development and maintenance of various tissues, most notably in the brain, eyes, and stomach.
Research and Clinical Significance
Research has established a strong link between biallelic mutations in MCOLN1 and Mucolipidosis type IV (MLIV). MLIV is a rare, autosomal recessive condition characterized by psychomotor delay, visual impairment, and other neurological symptoms. Because it is recessive, an individual must inherit two copies of a pathogenic mutation—one from each parent—to manifest the disease. The rs77574888 variant is one of the most common mutations identified in individuals of Ashkenazi Jewish descent who are carriers of MLIV. While the evidence for its role in causing the disorder is well-documented in clinical genetics, it is important to note that being a carrier (having one copy of the variant) does not typically result in the symptoms of the disease. Clinical screening for this variant is routinely offered to prospective parents in high-risk populations to provide information regarding the potential risk of passing the condition to offspring.
Population Frequency
The frequency of the rs77574888 variant varies significantly across different global populations. It is most notably associated with the Ashkenazi Jewish population, where the carrier frequency is estimated to be approximately 1 in 100. In the broader global population, this specific variant is extremely rare. Because of its higher prevalence in specific ancestral groups, it is included in standard carrier screening panels for those of Ashkenazi Jewish heritage. These panels are designed to help individuals understand their reproductive risks. It is important to remember that population statistics are averages and do not predict the health of any specific individual. Genetic screening results should always be interpreted by a qualified genetic counselor or medical professional who can provide context based on personal and family history.
What You Can Do With This Information
If you have received information about your status regarding the rs77574888 variant, the most important step is to consult with a healthcare provider or a certified genetic counselor. This information is primarily intended for reproductive planning and carrier screening purposes. If you are a carrier, it simply means you have one copy of the variant, which does not cause the disease in you. However, if your partner is also a carrier, there may be a risk of having a child with Mucolipidosis type IV. You cannot use this information to diagnose yourself or others with a medical condition, nor should it be used to make independent medical decisions. A professional can help you understand the implications of your results, discuss the limitations of genetic testing, and provide guidance on the next steps for your family planning or health management.
How common is this variant?
The rs77574888 variant has an allele frequency of approximately 0.007 in the Ashkenazi Jewish population, making it a significant target for carrier screening in this group.
Frequently asked questions
What is Mucolipidosis type IV?
Mucolipidosis type IV is a rare, inherited lysosomal storage disorder that affects the body's ability to recycle cellular waste. It typically presents in infancy with symptoms like delayed development and vision problems.
Does being a carrier for rs77574888 mean I have the disease?
No, being a carrier means you have one copy of the variant, but you do not have the disease. Mucolipidosis type IV is an autosomal recessive condition, meaning it requires two copies of a pathogenic mutation to manifest.
Why is this variant tested in Ashkenazi Jewish populations?
This variant is more common in individuals of Ashkenazi Jewish descent compared to the general population. Carrier screening is offered to help these individuals understand their reproductive risks.
What should I do if I am a carrier?
If you are a carrier, you should speak with a genetic counselor. They can explain the risks to your future children and discuss testing options for your partner.
Sources & further reading
Educational information only, last refreshed 9/23/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs77574888?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29